NPR; Philosophy Professor Helps To Solve Ethical Problems During Lockdown
"David Chan, a philosophy professor at the University of Alabama at Birmingham, puzzles over the moral quandaries listeners face during the coronavirus outbreak."
Issues and developments related to ethics, information, and technologies, examined in the ethics and intellectual property graduate courses I teach at the University of Pittsburgh School of Computing and Information. My Bloomsbury book "Ethics, Information, and Technology" will be published in Summer 2025. Kip Currier, PhD, JD
"Some in Silicon Valley dismiss the criticisms against Facebook as schadenfreude: Just like taxi drivers don't like Uber, legacy media envies the success of the social platform and enjoys seeing its leadership on the hot seat. A former employee is not so dismissive and says there is a cultural problem, a stubborn blindness at Facebook and other leading Internet companies like Twitter. The source says: "The hardest problems these companies face aren't technological. They are ethical, and there's not as much rigor in how it's done." At a values level, some experts point out, Facebook has to decide if its solution is free speech (the more people post, the more the truth rises), or clear restrictions."
"These days, of course, medical research is not just a scholarly affair. It is also a global, multibillion-dollar business enterprise, powered by the pharmaceutical and medical-device industries. The ethical problem today is not merely that these corporations have plenty of money to grease the wheels of university research. It’s also that researchers themselves are often given powerful financial incentives to do unethical things: pressure vulnerable subjects to enroll in studies, fudge diagnoses to recruit otherwise ineligible subjects and keep subjects in studies even when they are doing poorly. In what other potentially dangerous industry do we rely on an honor code to keep people safe? Imagine if inspectors never actually set foot in meatpacking plants or coal mines, but gave approvals based entirely on paperwork filled out by the owners. With so much money at stake in drug research, research subjects need a full-blown regulatory system. I.R.B.s should be replaced with oversight bodies that are fully independent — both financially and institutionally — of the research they are overseeing. These bodies must have the staffing and the authority to monitor research on the ground. And they must have the power to punish researchers who break the rules and institutions that cover up wrongdoing."